Scientists have uncovered an unexpected reason why some cancers return after initially responding to treatment.

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

The first two years after completing cancer treatment are considered the most important period for follow-up. Nearly 90 per cent of recurrences of the same cancer type occur within this timeframe.

In December, Detroit-based Barbara Ann Karmanos Cancer Center became the first facility in the world to offer at-home liver cancer treatment with the TheraBionic P1, a device recently approved by the ...

Bladder cancer is the sixth most common cancer in the U.S. People diagnosed with bladder cancer in northwestern Pennsylvania ...

The 5-mg dose of oxybutynin reduced the frequency and severity of hot flashes in men with prostate cancer undergoing treatment with androgen-deprivation therapy compared with placebo.

Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.